Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda M Dudek

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Therapy. Advances|June 1, 2026
It takes two: A two-component system to visualize single-molecule HIV-1 infection <i>in vivo</i>Amanda M Dudek
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2019
AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCsAmanda M Dudek, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"Amanda M Dudek, Matthew H Porteus
Journal of Virology|January 19, 2018
An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV ReceptorAmanda M Dudek, Sirika Pillay, Andreas S Puschnik, et al.
Nucleic Acids Research|March 28, 2019
Differential role for phosphorylation in alternative polyadenylation function versus nuclear import of SR-like protein CPSF6Sooin Jang, Nicola J Cook, Valerie E Pye, et al.
Cell Stem Cell|April 5, 2024
A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infectionAmanda M Dudek, William N Feist, Elena J Sasu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 1, 2019
GPR108 Is a Highly Conserved AAV Entry FactorAmanda M Dudek, Nerea Zabaleta, Eric Zinn, et al.
Nature Communications|January 3, 2024
Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cellsRon Baik, M Kyle Cromer, Steve E Glenn, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic AntibodiesWilliam N Feist, Sofia E Luna, Kaya Ben-Efraim, et al.
Nature Communications|March 31, 2025
Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodiesWilliam N Feist, Sofia E Luna, Kaya Ben-Efraim, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Therapy. Advances|June 1, 2026
It takes two: A two-component system to visualize single-molecule HIV-1 infection <i>in vivo</i>Amanda M Dudek
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2019
AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCsAmanda M Dudek, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"Amanda M Dudek, Matthew H Porteus
Journal of Virology|January 19, 2018
An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV ReceptorAmanda M Dudek, Sirika Pillay, Andreas S Puschnik, et al.
Nucleic Acids Research|March 28, 2019
Differential role for phosphorylation in alternative polyadenylation function versus nuclear import of SR-like protein CPSF6Sooin Jang, Nicola J Cook, Valerie E Pye, et al.
Cell Stem Cell|April 5, 2024
A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infectionAmanda M Dudek, William N Feist, Elena J Sasu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 1, 2019
GPR108 Is a Highly Conserved AAV Entry FactorAmanda M Dudek, Nerea Zabaleta, Eric Zinn, et al.
Nature Communications|January 3, 2024
Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cellsRon Baik, M Kyle Cromer, Steve E Glenn, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic AntibodiesWilliam N Feist, Sofia E Luna, Kaya Ben-Efraim, et al.
Nature Communications|March 31, 2025
Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodiesWilliam N Feist, Sofia E Luna, Kaya Ben-Efraim, et al.
Pageof 2